Yu Pan
Zhejiang University
11 Papers
4 Citations
Yu Pan is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 6 publications. Previous affiliations of Yu Pan include Sir Run Run Shaw Hospital.
Chat about Author
Papers
Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics.
TL;DR: HexB7 is generally overexpressed in GC, associated with patient clinical characteristics, and specifically promotes GC cell malignant biological properties through PIK3R3/AKT signaling pathways, indicating HOXB7 as a causal factor in promoting tumor progression.
24
Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease
TL;DR: Li et al. as discussed by the authors analyzed the protection of Auricularia cornea var. polysaccharides on high-fat diet (HFD)-induced NAFLD and mechanistic actions.
7
Laparoscopic pancreaticodoudenectomy: An excellent approach in elderly patients, a multicenter, comparative study.
Maher Hendi,Yi-Ping Mou,Chao Lu,Yu Pan,Yu Pan,Bin Zhang,Bin Zhang,Ke Chen,Xiao-Wu Xu,Renchao Zhang,Yucheng Zhou,Weiwei Jin +11 more
TL;DR: Elderly patients who underwent LPD in this study had good overall outcomes after LPD that were similar to young patients, and it is suggested that elderly patients with comorbidities should be more stringently selected for surgery.
6
[Restless legs syndrome in ischemic stroke patients: clinical features and significance].
Lisan Zhang,Yi Sun,Tiantian Wang,Yu Pan,Ying Yao,Liuqing Pan,Qinglin Xu,Wenying Zhang,Jiahui Xu,Xingyue Hu +9 more
TL;DR: RLS is common in ischemic stroke patients and has adverse influences on patients, and generalized linear model and logistic regression showed that low serum ferritin level, subcortical infarction, and moderate-severe depression were identified as the risk factors of RLS in ischemia stroke patients.
4
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
TL;DR: Immune-related RNA signature predicts the outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma, which could be tested as a biomarker for immune-chemotherapy in the future.
4